News and Announcements
YPB Enters into Joint Venture with Affyrmx
- Published February 11, 2016 12:10PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
10th February 2016, ASX Announcement
YPB Group Limited (ASX:YPB) has entered into an exclusive joint venture and consulting agreement with Affyrmx Group LLC focused on the protection of government, including but not limited to visas, vital record documents, ID cards and financial instruments including currency, in Latin America.
The agreement has a six year duration and will initially target federal and state government agencies in Mexico, aiming to integrate YPB’s Protect and Detect patented technologies within a range of high security printing services to protect high security, high value documents from counterfeiting.
Based in Atlanta, Georgia, Affyrmx was founded in 2011 and is a trusted security provider and adviser, primarily to governments and central banks in Latin America. The company offers a full range of high security products and solutions, all of which are designed to help governments combat the growing security threat posed by counterfieters.
To read the full announcement, please click here.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
